Arix Bioscience - Interview with Harpoon Therapeutics CEO Jerry McMahon
ARIX Wed, 18 Dec 2019, 09:15 GMT
Jerry McMahon discusses Harpoon's novel antibody-derived platform which has been designed to use t-cells to target and destroy solid tumors in prostate, ovarian, pancreatic and other solid cancers.

Arix Bioscience
Management Team
Mark Chin, Managing Director
Thu, 5 May 2022, 12:00pm BST
Naseem Amin, MD, Executive Chairman
Tue, 9 Mar 2021, 12:00pm GMT
Arix Bioscience, Management Team
Tue, 8 Sep 2020, 12:30pm BST
Arix Bioscience, Management Team
Tue, 10 Mar 2020, 12:15pm GMT
Arix Bioscience, Management Team
Wed, 18 Dec 2019, 9:15am GMT
Arix Bioscience, Management Team
Wed, 11 Dec 2019, 9:00am GMT
Arix Bioscience, Management Team
Wed, 4 Dec 2019, 9:10am GMT
Arix Bioscience, Management Team
Mon, 2 Dec 2019, 8:50am GMT
Arix Bioscience, Management Team
Wed, 28 Aug 2019, 12:30pm BST
Arix Bioscience, Management Team
Thu, 28 Mar 2019, 12:45pm GMT
Joe Anderson, PhD, Chief Executive Officer
Mon, 30 Jul 2018, 3:31pm BST
Jonathan Peacock, Chairman
Mon, 5 Mar 2018, 12:00pm GMT
Joe Anderson, PhD, Chief Executive Officer
Fri, 24 Feb 2017, 8:00am GMT